Mechanisms of regulation for interleukin-1β in neurodegenerative disease

Neuropharmacology

Volumn 52, Issue 8, 2007, Pages 1563-1569

  Simi, Anastasia ^a   Lerouet, Dominique ^a   Pinteaux, Emmanuel ^a   Brough, David ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Caspase 1; Cerebral ischemia; Inflammasome; Interleukin 1 ; P2X7 receptor; TLR4

Indexed keywords

ANTIINFLAMMATORY AGENT; CASPASE INHIBITOR; CYTOKINE RECEPTOR ANTAGONIST; E 5564; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPID A DERIVATIVE; PURINE P2X7 RECEPTOR; RECEPTOR BLOCKING AGENT; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; BRAIN DAMAGE; BRAIN ISCHEMIA; CELL DEATH; CLINICAL TRIAL; CYTOKINE RELEASE; CYTOLYSIS; DEGENERATIVE DISEASE; DRUG INHIBITION; DRUG SYNTHESIS; ELECTRON MICROSCOPY; ENZYME ACTIVATION; HUMAN; IMMUNOCOMPETENT CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN TARGETING; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; STROKE;

ANIMALS; BRAIN; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1BETA; NEURODEGENERATIVE DISEASES;

EID: 34249732616     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.02.011     Document Type: Review

References (88)

1. Allan S.M., and Rothwell N.J. Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2 (2001) 734-744
2. Andrei C., Dazzi C., Lotti L., Torrisi M.R., Chimini G., and Rubartelli A. The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. Mol. Biol. Cell 10 (1999) 1463-1475
3. Andrei C., Margiocco P., Poggi A., Lotti L.V., Torrisi M.R., and Rubartelli A. Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: implications for inflammatory processes. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 9745-9750
4. Barone F.C., Irving E.A., Ray A.M., Lee J.C., Kassis S., Kumar S., Badger A.M., Legos J.J., Erhardt J.A., Ohlstein E.H., Hunter A.J., Harrison D.C., Philpott K., Smith B.R., Adams J.L., and Parsons A.A. Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med. Res. Rev. 21 (2001) 129-145
5. Bianco F., Pravettoni E., Colombo A., Schenk U., Moller T., Matteoli M., and Verderio C. Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. J. Immunol. 174 (2005) 7268-7277
6. Black R.A., Kronheim S.R., Cantrell M., Deeley M.C., March C.J., Prickett K.S., Wignall J., Conlon P.J., Cosman D., and Hopp T.P. Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J. Biol. Chem. 263 (1988) 9437-9442
7. Boutin H., LeFeuvre R.A., Horai R., Asano M., Iwakura Y., and Rothwell N.J. Role of IL-1alpha and IL-1beta in ischemic brain damage. J. Neurosci. 21 (2001) 5528-5534
8. Braddock M., and Quinn A. Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention. Nat. Rev. Drug Discov. 3 (2004) 330-339
9. Bresnihan B. The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis. Semin. Arthritis Rheum. 30 (2001) 17-20
10. Brough D., and Rothwell N.J. Caspase-1-dependent processing of pro-interleukin-1beta is cytosolic and precedes cell death. J. Cell Sci. 120 (2007) 772-781
11. Brough D., Le Feuvre R.A., Iwakura Y., and Rothwell N.J. Purinergic (P2X7) receptor activation of microglia induces cell death via an interleukin-1-independent mechanism. Mol. Cell Neurosci. 19 (2002) 272-280
12. Brough D., Le Feuvre R.A., Wheeler R.D., Solovyova N., Hilfiker S., Rothwell N.J., and Verkhratsky A. Ca2+ stores and Ca2+ entry differentially contribute to the release of IL-1 beta and IL-1 alpha from murine macrophages. J. Immunol. 170 (2003) 3029-3036
13. Chakfe Y., Seguin R., Antel J.P., Morissette C., Malo D., Henderson D., and Seguela P. ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels. J. Neurosci. 22 (2002) 3061-3069
14. Chauvet N., Palin K., Verrier D., Poole S., Dantzer R., and Lestage J. Rat microglial cells secrete predominantly the precursor of interleukin-1beta in response to lipopolysaccharide. Eur. J. Neurosci. 14 (2001) 609-617
15. Coeshott C., Ohnemus C., Pilyavskaya A., Ross S., Wieczorek M., Kroona H., Leimer A.H., and Cheronis J. Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 6261-6266
16. Collino M., Aragno M., Mastrocola R., Gallicchio M., Rosa A.C., Dianzani C., Danni O., Thiemermann C., and Fantozzi R. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur. J. Pharmacol. 530 (2006) 70-80
17. Elssner A., Duncan M., Gavrilin M., and Wewers M.D. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J. Immunol. 172 (2004) 4987-4994
18. Emsley H.C., Smith C.J., Georgiou R.F., Vail A., Hopkins S.J., Rothwell N.J., and Tyrrell P.J. A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J. Neurol. Neurosurg. Psychiatry 76 (2005) 1366-1372
19. Esposito G., De F.D., Cirillo C., Sarnelli G., Cuomo R., and Iuvone T. The astroglial-derived S100beta protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation. Life Sci. 78 (2006) 2707-2715
20. Fantuzzi G., Ku G., Harding M.W., Livingston D.J., Sipe J.D., Kuida K., Flavell R.A., and Dinarello C.A. Response to local inflammation of IL-1 beta-converting enzyme-deficient mice. J. Immunol. 158 (1997) 1818-1824
21. Ferrari D., Chiozzi P., Falzoni S., Dal S.M., Melchiorri L., Baricordi O.R., and Di V.F. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159 (1997) 1451-1458
22. Ferrari D., Chiozzi P., Falzoni S., Hanau S., and Di V.F. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185 (1997) 579-582
23. Giovannini M.G., Scali C., Prosperi C., Bellucci A., Vannucchi M.G., Rosi S., Pepeu G., and Casamenti F. Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway. Neurobiol. Dis. 11 (2002) 257-274
24. Grahames C.B., Michel A.D., Chessell I.P., and Humphrey P.P. Pharmacological characterization of ATP- and LPS-induced IL-1beta release in human monocytes. Br. J. Pharmacol. 127 (1999) 1915-1921
25. Griffiths R.J., Stam E.J., Downs J.T., and Otterness I.G. ATP induces the release of IL-1 from LPS-primed cells in vivo. J. Immunol. 154 (1995) 2821-2828
26. Gudipaty L., Munetz J., Verhoef P.A., and Dubyak G.R. Essential role for Ca2+ in regulation of IL-1beta secretion by P2X7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells. Am. J. Physiol. Cell Physiol. 285 (2003) C286-C299
27. Hauff K., Zamzow C., Law W.J., De M.J., Kennedy K., and Los M. Peptide-based approaches to treat asthma, arthritis, other autoimmune diseases and pathologies of the central nervous system. Arch. Immunol. Ther. Exp. (Warsz.) 53 (2005) 308-320
28. Hawkins L.D., Christ W.J., and Rossignol D.P. Inhibition of endotoxin response by synthetic TLR4 antagonists. Curr. Top. Med. Chem. 4 (2004) 1147-1171
29. Hogquist K.A., Unanue E.R., and Chaplin D.D. Release of IL-1 from mononuclear phagocytes. J. Immunol. 147 (1991) 2181-2186
30. Ichikawa K., Hirai H., Ishiguro M., Kambara T., Kato Y., Kim Y.J., Kojima Y., Matsunaga Y., Nishida H., Shiomi Y., Yoshikawa N., Huang L.H., and Kojima N. Cytokine production inhibitors produced by a fungus, Oidiodendron griseum. J. Antibiot. (Tokyo) 54 (2001) 697-702
31. Ichikawa K., Hirai H., Ishiguro M., Kambara T., Kato Y., Kim Y.J., Kojima Y., Matsunaga Y., Nishida H., Shiomi Y., Yoshikawa N., and Kojima N. Novel cytokine production inhibitors produced by a basidiomycete, Marasmiellus sp. J. Antibiot. (Tokyo) 54 (2001) 703-709
32. Irmler M., Hertig S., MacDonald H.R., Sadoul R., Becherer J.D., Proudfoot A., Solari R., and Tschopp J. Granzyme A is an interleukin 1 beta-converting enzyme. J. Exp. Med. 181 (1995) 1917-1922
33. Irving E.A., Barone F.C., Reith A.D., Hadingham S.J., and Parsons A.A. Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat. Brain Res. Mol. Brain Res. 77 (2000) 65-75
34. Jou I., Lee J.H., Park S.Y., Yoon H.J., Joe E.H., and Park E.J. Gangliosides trigger inflammatory responses via TLR4 in brain glia. Am. J. Pathol. 168 (2006) 1619-1630
35. Kakimura J., Kitamura Y., Takata K., Umeki M., Suzuki S., Shibagaki K., Taniguchi T., Nomura Y., Gebicke-Haerter P.J., Smith M.A., Perry G., and Shimohama S. Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins. FASEB J. 16 (2002) 601-603
36. Kern J.A., Warnock L.J., and McCafferty J.D. The 3′ untranslated region of IL-1beta regulates protein production. J. Immunol. 158 (1997) 1187-1193
37. Kim N.G., Lee H., Son E., Kwon O.Y., Park J.Y., Park J.H., Cho G.J., Choi W.S., and Suk K. Hypoxic induction of caspase-11/caspase-1/interleukin-1beta in brain microglia. Brain Res. Mol. Brain Res. 114 (2003) 107-114
38. Kim S.H., Smith C.J., and Van Eldik L.J. Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1 beta production. Neurobiol. Aging 25 (2004) 431-439
39. Kotlyarov A., Neininger A., Schubert C., Eckert R., Birchmeier C., Volk H.D., and Gaestel M. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat. Cell Biol. 1 (1999) 94-97
40. Laliberte R.E., Perregaux D.G., Hoth L.R., Rosner P.J., Jordan C.K., Peese K.M., Eggler J.F., Dombroski M.A., Geoghegan K.F., and Gabel C.A. Glutathione S-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing. J. Biol. Chem. 278 (2003) 16567-16578
41. Lawrence C.B., Allan S.M., and Rothwell N.J. Interleukin-1beta and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur. J. Neurosci. 10 (1998) 1188-1195
42. Le Feuvre R.A., Brough D., Iwakura Y., Takeda K., and Rothwell N.J. Priming of macrophages with lipopolysaccharide potentiates P2X7-mediated cell death via a caspase-1-dependent mechanism, independently of cytokine production. J. Biol. Chem. 277 (2002) 3210-3218
43. Le Feuvre R.A., Brough D., and Rothwell N. Extracellular ATP and P2X7 receptors in neurodegeneration. Eur. J. Pharmacol. 447 (2002) 261-269
44. Le Feuvre R.A., Brough D., Touzani O., and Rothwell N.J. Role of P2X7 receptors in ischemic and excitotoxic brain injury in vivo. J. Cereb. Blood Flow Metab. 23 (2003) 381-384
45. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal M.J., Heys J.R., Landvatter S.W., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372 (1994) 739-746
46. Lu C., Wang Y., Furukawa K., Fu W., Ouyang X., and Mattson M.P. Evidence that caspase-1 is a negative regulator of AMPA receptor-mediated long-term potentiation at hippocampal synapses. J. Neurochem. 97 (2006) 1104-1110
47. Lucas S.M., Rothwell N.J., and Gibson R.M. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147 Suppl. 1 (2006) S232-S240
48. Mabuchi T., Kitagawa K., Ohtsuki T., Kuwabara K., Yagita Y., Yanagihara T., Hori M., and Matsumoto M. Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke 31 (2000) 1735-1743
49. MacKenzie A., Wilson H.L., Kiss-Toth E., Dower S.K., North R.A., and Surprenant A. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15 (2001) 825-835
50. Mariathasan S., Weiss D.S., Newton K., McBride J., O'Rourke K., Roose-Girma M., Lee W.P., Weinrauch Y., Monack D.M., and Dixit V.M. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440 (2006) 228-232
51. Martinon F., Burns K., and Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10 (2002) 417-426
52. McLarnon J.G., Ryu J.K., Walker D.G., and Choi H.B. Upregulated expression of purinergic P2X(7) receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus. J. Neuropathol. Exp. Neurol. 65 (2006) 1090-1097
53. Melani A., Turchi D., Vannucchi M.G., Cipriani S., Gianfriddo M., and Pedata F. ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia. Neurochem. Int. 47 (2005) 442-448
54. Melani A., Amadio S., Gianfriddo M., Vannucchi M.G., Volonte C., Bernardi G., Pedata F., and Sancesario G. P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat. J. Cereb. Blood Flow Metab. 26 (2006) 974-982
55. North R.A., and Surprenant A. Pharmacology of cloned P2X receptors. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 563-580
56. Ogura Y., Sutterwala F.S., and Flavell R.A. The inflammasome: first line of the immune response to cell stress. Cell 126 (2006) 659-662
57. Okamura Y., Watari M., Jerud E.S., Young D.W., Ishizaka S.T., Rose J., Chow J.C., and Strauss III J.F. The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276 (2001) 10229-10233
58. Oyama J., Blais Jr. C., Liu X., Pu M., Kobzik L., Kelly R.A., and Bourcier T. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109 (2004) 784-789
59. Parvathenani L.K., Tertyshnikova S., Greco C.R., Roberts S.B., Robertson B., and Posmantur R. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem. 278 (2003) 13309-13317
60. Pearson V.L., Rothwell N.J., and Toulmond S. Excitotoxic brain damage in the rat induces interleukin-1beta protein in microglia and astrocytes: correlation with the progression of cell death. Glia 25 (1999) 311-323
61. Pelegrin P., and Surprenant A. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J. 25 (2006) 5071-5082
62. Pelegrin P., and Surprenant A. Pannexin-1 couples to maitotoxin- and nigericin-induced interleukin-1beta release through a dye uptake-independent pathway. J. Biol. Chem. 282 (2007) 2386-2394
63. Perregaux D., and Gabel C.A. Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J. Biol. Chem. 269 (1994) 15195-15203
64. Perregaux D.G., and Gabel C.A. Human monocyte stimulus-coupled IL-1beta posttranslational processing: modulation via monovalent cations. Am. J. Physiol. 275 (1998) C1538-C1547
65. Perregaux D.G., and Gabel C.A. Post-translational processing of murine IL-1: evidence that ATP-induced release of IL-1 alpha and IL-1 beta occurs via a similar mechanism. J. Immunol. 160 (1998) 2469-2477
66. Perregaux D.G., Laliberte R.E., and Gabel C.A. Human monocyte interleukin-1beta posttranslational processing. Evidence of a volume-regulated response. J. Biol. Chem. 271 (1996) 29830-29838
67. Perregaux D.G., McNiff P., Laliberte R., Hawryluk N., Peurano H., Stam E., Eggler J., Griffiths R., Dombroski M.A., and Gabel C.A. Identification and characterization of a novel class of interleukin-1 post-translational processing inhibitors. J. Pharmacol. Exp. Ther. 299 (2001) 187-197
68. Prudovsky I., Mandinova A., Soldi R., Bagala C., Graziani I., Landriscina M., Tarantini F., Duarte M., Bellum S., Doherty H., and Maciag T. The non-classical export routes: FGF1 and IL-1alpha point the way. J. Cell Sci. 116 (2003) 4871-4881
69. Rubartelli A., Cozzolino F., Talio M., and Sitia R. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J. 9 (1990) 1503-1510
70. Rudolphi K., Gerwin N., Verzijl N., van der K.P., and van den B.W. Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis. Osteoarthritis Cartilage 11 (2003) 738-746
71. Schielke G.P., Yang G.Y., Shivers B.D., and Betz A.L. Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J. Cereb. Blood Flow Metab. 18 (1998) 180-185
72. Schonbeck U., Mach F., and Libby P. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J. Immunol. 161 (1998) 3340-3346
73. Seman M., Adriouch S., Scheuplein F., Krebs C., Freese D., Glowacki G., Deterre P., Haag F., and Koch-Nolte F. NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 19 (2003) 571-582
74. Sim J.A., Young M.T., Sung H.Y., North R.A., and Surprenant A. Reanalysis of P2X7 receptor expression in rodent brain. J. Neurosci. 24 (2004) 6307-6314
75. Simi A., Porsmyr-Palmertz M., Hjerten A., Ingelman-Sundberg M., and Tindberg N. The neuroprotective agents chlomethiazole and SB203580 inhibit IL-1beta signalling but not its biosynthesis in rat cortical glial cells. J. Neurochem. 83 (2002) 727-737
76. Singer I.I., Scott S., Chin J., Bayne E.K., Limjuco G., Weidner J., Miller D.K., Chapman K., and Kostura M.J. The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. J. Exp. Med. 182 (1995) 1447-1459
77. Solle M., Labasi J., Perregaux D.G., Stam E., Petrushova N., Koller B.H., Griffiths R.J., and Gabel C.A. Altered cytokine production in mice lacking P2X(7) receptors. J. Biol. Chem. 276 (2001) 125-132
78. Tanga F.Y., Nutile-McMenemy N., and DeLeo J.A. The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 5856-5861
79. Thornberry N.A., Bull H.G., Calaycay J.R., Chapman K.T., Howard A.D., Kostura M.J., Miller D.K., Molineaux S.M., Weidner J.R., Aunins J., et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356 (1992) 768-774
80. Tsan M.F., and Gao B. Endogenous ligands of Toll-like receptors. J. Leukoc. Biol. 76 (2004) 514-519
81. Virginio C., MacKenzie A., North R.A., and Surprenant A. Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J. Physiol. 519 Pt 2 (1999) 335-346
82. Walton K.M., DiRocco R., Bartlett B.A., Koury E., Marcy V.R., Jarvis B., Schaefer E.M., and Bhat R.V. Activation of p38MAPK in microglia after ischemia. J. Neurochem. 70 (1998) 1764-1767
83. Wang X., Xu L., Wang H., Young P.R., Gaestel M., and Feuerstein G.Z. Mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 deficiency protects brain from ischemic injury in mice. J. Biol. Chem. 277 (2002) 43968-43972
84. Watkins L.R., Hansen M.K., Nguyen K.T., Lee J.E., and Maier S.F. Dynamic regulation of the proinflammatory cytokine, interleukin-1beta: molecular biology for non-molecular biologists. Life Sci. 65 (1999) 449-481
85. Wilson K.P., Black J.A., Thomson J.A., Kim E.E., Griffith J.P., Navia M.A., Murcko M.A., Chambers S.P., Aldape R.A., Raybuck S.A., et al. Structure and mechanism of interleukin-1 beta converting enzyme. Nature 370 (1994) 270-275
86. Young P., McDonnell P., Dunnington D., Hand A., Laydon J., and Lee J. Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein level. Agents Actions 39 Spec No (1993) C67-C69
87. Zhai Y., Shen X.D., O'Connell R., Gao F., Lassman C., Busuttil R.W., Cheng G., and Kupiec-Weglinski J.W. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J. Immunol. 173 (2004) 7115-7119
88. Zhang W., Petrovic J.M., Callaghan D., Jones A., Cui H., Howlett C., and Stanimirovic D. Evidence that hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of interleukin-1beta (IL-1beta) in astrocyte cultures. J. Neuroimmunol. 174 (2006) 63-73